Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Qsymia (phentermine/topiramate) and Zepbound (tirzepatide) are both medications used to help with weight loss, but they belong to different drug classes and have distinct uses. Qsymia is a combination of a sympathomimetic and an antiepileptic medication, while Zepbound is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Both medications are used for weight management in adults who have obesity or who have overweight with at least one weight-related condition. Zepbound is also approved for treating moderate-to-severe sleep apnea. Qsymia is taken orally once a day, whereas Zepbound is injected under the skin once a week. Both Qsymia and Zepbound are only available as brand-name medications. Common side effects of Qsymia include dry mouth and constipation, while Zepbound can cause nausea and diarrhea. Qsymia is a controlled substance due to the phentermine component, whereas Zepbound is not a controlled medication. Additionally, Zepbound has potential interactions with diabetes medications, warfarin (Jantoven, Coumadin), and birth control pills. Qsymia can also interact with birth control pills as well as alcohol and medications that cause drowsiness.
Qsymia (phentermine / topiramate ER)
Zepbound (tirzepatide)
Qsymia (phentermine / topiramate ER)
Zepbound (tirzepatide)
Summary of Qsymia vs. Zepbound
Summary for Sympathomimetic / Antiepileptic
Prescription only
Qsymia (phentermine / topiramate extended release) is a combination medication used to help with weight loss. It's approved for people over 12 who are considered obese and for some adults who are considered overweight. This medication is a tablet that you take once a day. You should also eat a balanced diet and exercise regularly for best results. Side effects include a "pins-and-needles" feeling, dry mouth, and constipation. You can only get this medication through the Qsymia REMS (Risk Evaluation and Mitigation Strategies) program because of the risk of birth defects if taken during pregnancy.
Summary for GIP and GLP-1 agonist
Prescription only
Zepbound (tirzepatide) is an injectable medication that's used along with diet and exercise. It helps with weight loss in adults who meet criteria for weight management therapy. It's also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The dosage is 1 injection under the skin once a week. Common side effects include nausea, diarrhea, and injection site reactions. Zepbound (tirzepatide) is only available as a brand-name medication.
Indications of Qsymia vs. Zepbound
Indications for
•Weight loss and long-term weight management, together with diet and exercise, for certain people: